• Home
  • >
  • Eiko Lifesciences Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/BlinkxSearch/initials/e.svg Logo

Eiko Lifesciences Ltd Financial Statement

Eiko Lifesciences Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue8.56.636.44
Operating Expense7.886.156.06
Net Profit0.310.240.12
Net Profit Margin3.653.621.86
Earning Per Share0.280.240.12
EBIDTA0.610.430.34
Effective Tax Rate15.87TBATBA

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Eiko Lifesciences Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2020Mar 2019Mar 2018
Total Revenue Annual10.44.252.34
Operating Expenses Annual14.924.961.99
Operating Profit Annual-4.51-0.650.41
Interest Annual0.230.170.08
Depreciation0.190.170.08
Net Profit Annual-1.91-0.440.2
Tax Annual-1.31-0.210.05

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Eiko Lifesciences Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2020Mar 2019Mar 2018
Cash Flow at the Beginning0.110.8TBA
Cash Flow from Operations-0.330.16TBA
Cash Flow from Investing-0.71-0.3TBA
Cash Flow from Financing0.95-0.55TBA
Cash Flow at the End0.020.11TBA

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Eiko Lifesciences Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2020Mar 2019Mar 2018
PBDIT Margin (%)-40.61-14.9917.8
PBIT Margin (%)-42.37-18.9714.41
PBT Margin (%)TBA1,060.52-726.77
Net PROFIT Margin (%)TBA17.9535.29
Return On Networth / Equity (%)TBATBA3.6
Return On Networth /Employed(%)TBATBA4.66
Return On Assets (%)TBA11.3110.94
Total Debt / Equity(X)0.050.060.09
Asset Turnover Ratio (%)3.20.630.31

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Eiko Lifesciences Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2020Mar 2019Mar 2018
Fixed Assets Annual1.751.711.68
Total Current Assets Annual5.034.175.98
Non Current Assets Annual7.035.134.98
Total Shareholders Funds Annual2.954.925.56
Total Assets Annual12.059.3110.95

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Eiko Lifesciences Ltd Earning Calls
Sep 2020
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Eiko Lifesciences Ltd has a market capitalization of 3.88 Cr. Value Research classifies it as a Micro-Cap company.

No, Eiko Lifesciences Ltd is not debt-free with a debt-to-equity ratio of 0.55.

In FY 2023, Eiko Lifesciences Ltd recorded a total revenue of approximately 10.35 Cr marking a significant milestone in the company's financial performance.

Eiko Lifesciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.8% and 0.7% annually, respectively..

Eiko Lifesciences Ltd's current PE ratio is -2.03.

Eiko Lifesciences Ltd's ROCE averaged -38.7% from the FY ending March 2018 to 2020, with a median of -13.1%. It peaked at 0.0% in March 2018, reflecting strong capital efficiency over the period..

Eiko Lifesciences Ltd's latest EBIT is Rs. -4.69 Cr, surpassing the average EBIT of Rs. -1.73 Cr over the 5 years..